Denileukin Diftitox
Denileukin Diftitox | |
---|---|
Term | Denileukin Diftitox |
Short definition | Denileukin Diftitox - (pronounced) (DEH-nih-LOO-kin DIF-tih-tox) drug used to treat adults with cutaneous T-cell lymphoma that has come back (recurred) or has not improved with other treatments. It is used in patients whose cancer has a receptor for the protein interleukin-2 (IL-2). |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Denileukin Diftitox - (pronounced) (DEH-nih-LOO-kin DIF-tih-tox) drug used to treat adults with cutaneous T-cell lymphoma that has come back (recurred) or has not improved with other treatments. It is used in patients whose cancer has a receptor for the protein interleukin-2 (IL-2). It is also being studied in the treatment of other types of cancer. Denileukin diftitox is made by combining IL-2 with a bacterial toxin. The IL-2 portion of the drug attaches to the cancer cells and the toxin kills them. Denileukin Diftitox is a type of immunotoxin and a type of fusion protein. Also called Ontak
External links
- Medical encyclopedia article on Denileukin Diftitox
- Wikipedia's article - Denileukin Diftitox
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski